Gene ID 30948
Formulation 50 µg (0.2 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 0.1% BSA and 0.02% thimerosal.
Antibody Target Bin1
Shipping gel pack
Concentration 0.2 mg/ml
Storage Temp. -20 °C
Appearance Colorless liquid
Research Use For Rersearch Use Only! Not to be used in humans.
Shelf Life 1 year
Handling The peptide solution should be gently mixed before use.
Test You can block the antibody by the specific target amino acid sequence of peptide.
Properties blocking peptide
Description Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
Short name Bin1 Blocking Peptide
Technique blocking peptide, Blocking, peptide
Alternative name bridging integrator 1 inhibiting short protein sequence
Alternative technique control
Alternative to gene target bridging integrator 1, AMPH2 and AMPHL and SH3P9, BIN1 and IDBG-68691 and ENSG00000136717 and 274, GTPase binding, nuclei, Bin1 and IDBG-133763 and ENSMUSG00000024381 and 30948, BIN1 and IDBG-639275 and ENSBTAG00000019177 and 614576